Markets.com Logo

OMER

$--
--%
1d
1w
1m

Analysis and statistics

  • Open
    4.1708$
  • Previous Close
    4.493$
  • 52 Week Change
    10.65$
  • Day Range
    -0.32$
  • 52 Week High/Low
    2.95$ - 13.6$
  • Dividend Per Share
    --
  • Market cap
    305 M$
  • EPS
    -0.43
  • Beta
    2.263
  • Volume
    --

About

OMER.US represents the common stock of Omeros Corporation, a biopharmaceutical company headquartered in Seattle, Washington. It is listed on the Nasdaq stock exchange. Omeros focuses on discovering, developing, and commercializing small-molecule and protein therapeutics for inflammation, complement-mediated diseases, and disorders of the central nervous system.

Gold's Safe-Haven Status Under Scrutiny: Market Dynamics and Price Outlook

Emma Rose|--

Trump's Iran War Exit Without a Deal: Reshaping Middle East Energy Security and Power Dynamics

Emma Rose|--
European market insights: What is the European stock market doing right now?

European market insights: What is the European stock market doing right now?

Ghko B|--
EUR/USD Analysis Today: EUR/USD Gains to 1.1550 as Middle East Uncertainty Lingers

EUR/USD Analysis Today: EUR/USD Gains to 1.1550 as Middle East Uncertainty Lingers

Ghko B|--

Microsoft at a Crossroads: AI Hurdles and Cloud Resilience Amidst Market Volatility

Sophia Claire|--

Iran's Hormuz Gambit: Leveraging a Chokepoint for Economic Leverage and Global Impact

Ava Grace|--

Gold Market Resilience: Navigating Sell-offs and Sustaining Bull Run

Noah Lee|--

Factors

Omeros Corporation's (OMER.US) stock price is influenced by several factors. Clinical Trial Results: Positive trial outcomes for Omeros' drugs, particularly OMS721 (narsoplimab), typically boost the stock, while failures can cause significant declines. Regulatory Decisions: FDA approvals or rejections of Omeros' drug applications greatly impact investor confidence and stock valuation. Financial Performance: Revenue, earnings, and cash flow figures directly reflect Omeros' business success and influence stock prices. Competition: The presence of rival therapies and competing drug development programs affects Omeros' market share potential. Market Sentiment: Overall investor attitude towards biotechnology stocks and the healthcare sector affects Omeros, even if the news about the company itself is limited. Patent Protection: The strength and duration of Omeros' patents are crucial for maintaining market exclusivity and, therefore, influencing the stock price. Partnerships and Acquisitions: Strategic collaborations or acquisitions by Omeros or its competitors can impact market perception and Omeros' future prospects. Macroeconomic Factors: Broad economic conditions, interest rates, and inflation can influence investor risk appetite and impact Omeros' stock. Management Changes: Significant shifts in the company's leadership team can signal potential changes in strategy and affect investor sentiment. Analyst Ratings: Recommendations and price targets from financial analysts can sway investor opinion and contribute to price fluctuations.

People Also Watch

Latest news

US Steel and Aluminum Tariffs Revamped: Simplification Amidst Potential Cost Increases

Noah Lee|--

SpaceX Files Secret IPO Bid, Eyeing Record-Breaking $1.75 Trillion Valuation

Ava Grace|--

US Intelligence: Iran Unwilling to Engage in Substantive Talks to End War

Sophia Claire|--

Latest Education Articles

What Is Sensex in Stock Market: Meaning, Calculation, and Why It Matters for Investors

What Is Sensex in Stock Market: Meaning, Calculation, and Why It Matters for Investors

Ghko B|--
Investing basics for beginners: What are the 4 economic indicators?

Investing basics for beginners: What are the 4 economic indicators?

Frances Wang|--
CFDs vs Options: What’s the Difference?

CFDs vs Options: What’s the Difference?

Julian Parker|--